Through computational tools, Valthos analyzes biological data to design adaptive solutions against emerging threats. PHOTO: VALTHOS
Reimagining biodefense at the intersection of AI, biology and urgency.
Updated
November 27, 2025 3:26 PM
Through computational tools, Valthos analyzes biological data to design adaptive solutions against emerging threats. PHOTO: VALTHOS
Valthos has raised US$30 million in seed funding, led by the OpenAI Startup Fund, Lux Capital and Founders Fund, to advance its mission of building next-generation biodefense systems.
The company’s work comes at a time when biotechnology is evolving at an unprecedented pace. Biotechnology is moving at record speed. These new tools can lead to life-changing medical discoveries, but they also bring the risk of dangerous biological agents being developed faster than ever.
“The issue at the core of biodefense is asymmetry”, said Kathleen McMahon, co-founder of Valthos. “It’s easier to make a pathogen than a cure. We’re building tools to help experts at the frontlines of biodefense move as fast as the threats they face”. The gap Valthos aims to close is between the rapid rise of biological threats and the slower pace of developing cures. Therefore, the company is developing AI systems that can rapidly analyze biological sequences and significantly shorten the time needed to design medical countermeasures.
“In this new world, the only way forward is to be faster. So we set out to build a new tech stack for biodefense”, said Tess van Stekelenburg, co-founder of Valthos. “This software infrastructure strengthens biodefense today and lays the groundwork for the adaptive, precision therapeutics of tomorrow”.
The company was founded by van Stekelenburg, a partner at Lux Capital and McMahon, the former head of Palantir’s Life Sciences division. Together, they’ve built a multidisciplinary team of experts from Palantir, DeepMind, Stanford’s Arc Institute and MIT’s Broad Institute, bringing together deep experience in software engineering, machine learning and biotechnology.
“Technology is moving fast. An industrial ecosystem of builders, companies and solutions further democratizes AI to provide broad resilience, and ensures the U.S. continues to lead as AI increasingly powers everything around us. As AI and biotech rapidly advance, biodefense is one of the new industry verticals that helps maximize the benefits and minimize the risks”, said Jason Kwon, OpenAI’s Chief Strategy Officer. “Valthos is pushing the frontier of protection and defense in one of the most strategic intersections of multiple world-changing technologies, and with the team to do it”.
Looking ahead, Valthos plans to expand its engineering team and scale its software infrastructure for both government and commercial partners — moving closer to its goal of enabling faster, smarter and more adaptive biodefense capabilities.
Keep Reading
Grab your popcorn—2026 is going to be a huge year for sci-fi fans. Big stories are hitting the big screen, from survival epics on a ruined Earth to time-bending adventures and eerie tales of AI love gone wrong. Some are fresh takes, others are long-awaited sequels, but all promise to keep you talking long after the credits roll. Here are five sci-fi movies you’ll want to mark on your calendar.
Release Date: January 9, 2026
Director: Kate Dolan
Stars: Lily Sullivan, David Rysdahl and Claudia Doumit
Soulm8te will take you to a dark AI universe. The film follows a grieving man who turns to an AI android to ease the pain of losing his wife. At first, the relationship feels like a second chance at love, but the bond soon spirals into a dangerous romance.
Noting how companion-style robots already exist in parts of the world, Wan and executive producer Allison Williams wanted to reimagine technology in the form of a female humanoid built for intimacy. Wan, who also directed M3GAN 2.0, another chilling story centered on an AI doll, brings that same unsettling vision to Soulm8te. Ultimately, what begins as comfort soon twists into obsession, turning desire into a deadly consequence.
.jpg)
Release Date: January 9, 2026
Director: Ric Roman Waugh,
Stars: Morena Baccarin, Amber Rose Revah, Sophie Thompson, Trond Fausa Aurvåg
Back in 2020, Greenland introduced audiences to John Garrity (Gerard Butler), a father racing against time to save his family as fragments of a comet threatened to wipe out life on Earth. The story ended with humanity’s last hope lying in survival bunkers deep in Greenland.
The sequel, Greenland: Migration, picks up several years later as the Garrity family emerges from shelter into a devastated world. Now set in post-apocalyptic Europe, John must lead his family across a dangerous wasteland in search of a new home. With survival once again at stake, the journey promises both peril and resilience.
Release Date: March 20, 2026
Director: Phil Lord & Chris Miller
Stars: Ryan Gosling, Milana Vayntrub, Sandra Hüller
Andy Weir’s sci-fi novel Project Hail Mary (from the author of The Martian) is headed to the big screen, with Ryan Gosling starring as Ryland Grace. Once a junior high science teacher, Grace wakes up inside a spaceship with no memory of who he is or why he’s there. He’s been in a coma for nearly four years, kept alive by advanced robotic arms that fed and rotated his body. Slowly, he recalls the truth: this is a suicide mission, with no fuel or food to bring him back home.
Turns out, his path to space began when Eva Stratt, head of a global task force, recruited him after reading his paper on alien survival without water. Now Grace must stop a deadly infestation of star-eating microbes called “astrophage” before they wipe out life on Earth.